Compositions and products for infectious or inflammatory diseases or conditions
Composition and methods for treating infectious and inflammatory diseases using saccharide based products and therapies. Products can be implemented as a nutritional supplement, a food, a feed, a food additive, a feed additive, a therapeutic product, a rehydration salt, or a rehydration solution. The present disclosure relates generally to the fields of compositions and products containing the compositions, and the use of the compositions or the products for preventing and/or treating infectious or inflammatory diseases or conditions in particular gastrointestinal and respiratory diseases (diarrhea and influenza infections) or inflammatory.
1. A method for treating an infectious disease, inflammatory disease or infection-relating disease or condition, the method comprising administering an effective amount of a composition to a patient diagnosed with an infectious disease, inflammatory disease or an infection-relating disease or condition, wherein the composition comprises:
(a) about 0.01 mg/mL to about 20 mg/mL of N-acetylneuraminic acid;
(b) about 0.01 mg/mL to about 20 mg/mL of N-acetylneuraminic acid methyl ester; and
(c) about ¼ to about ¾ of the manufacturer's recommended dose of Tamiflu for the treatment of influenza; or
(d) about ¼ to about ¾ of the manufacturer's recommended dose of Enrofloxacin for the treatment of rotavirus infection or diarrhea; or
(e) about ¼ to about ¾ of the manufacturer's recommended dose of Cephradine for the treatment of diarrhea gastroenteritis; and
wherein the infectious disease, inflammatory disease or an infection-relating disease or condition is gastroenteritis, diarrhea, or viral infection caused by influenza or rotavirus.
2. The method of claim 1 , wherein the administration is subcutaneous, topical, oral, intramuscular, intravenous, intraperitoneal, intracavital, or transdermal, or via inhalation.
3. The method of claim 1 , wherein the patient is an animal, wherein the animal is a cow, pig, horse, sheep, goat, llama, cattle, donkey,chicken, duck, goose, turkey, pigeon, a dog, a cat, a rodent, bird, a fish, a shrimp, an oyster, a crustacean, or a mollusk.
4. The method of claim 1 , wherein the patient is a human.
5. A method for treating an infectious disease, inflammatory disease or infection-relating disease or condition with a reduced amount of antibiotic, the method comprising:
administering to a patient diagnosed with an infectious disease, inflammatory disease or an infection-relating disease or condition an effective amount of a composition comprising N-acetylneuraminic acid or N-acetylneuraminic acid and an antibiotic,
wherein the composition comprises an amount of the antibiotic is about 10% to about 75% less than the amount of the antibiotic if the antibiotic had been used alone, and
wherein the infectious disease, inflammatory disease or an infection-relating disease or condition is gastroenteritis, diarrhea, or viral infection caused by influenza or rotavirus.
6. The method of claim 5 , wherein the composition further comprises at least one of:
N-acetylneuraminic acid methyl ester; or
a methionine.